AbbVie Earnings Preview: What to Expect

AbbVie is set to release its first-quarter earnings report, with analysts anticipating a strong performance driven by its immunology and oncology segments. Key areas to watch include the sales trajectory of Skyrizi and Rinvoq, as well as updates on the company's pipeline and any potential impacts from ongoing litigation. Investors will be looking for guidance on future growth and profitability.